Publication Topic

Scott P, Haws LC, Scott L, Harris M. 2007. Evaluation of background dioxin-like PCB congener profiles in human serum collected during NHANES 2001-2002 using principal components analysis. Dioxin 2007, September 2-7, 2007. Tokyo, Japan.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.

Staskal DF, Unice KM, Walker NJ, DeVito MJ, Birnbaum LS, Scott PK,…, Finley BL, Haws LC. An alternative method for establishing TEFs for dioxin-like compounds: Part 3. Development of weighted distributions of REPs for PCB126 and 2,3,4,7,8-PeCDF. Dioxin 2006, Oslo, Norway, August 2006.

Scott PK, Haws LC, Staskal DF, Birnbaum LS, Walker NJ, DeVito MJ, Harris MA…, Finley BL, et al. An alternative method for establishing TEFs for dioxin-like compounds: Part 1. Evaluation of decision analysis methods for use in weighting relative potency data. Dioxin 2006, Oslo, Norway, August 2006.

Staskal DF, Ferriby LL, Williams ES, Luksemburg WJ, Haws LC, Birnbaum LS, Paustenbach DJ, Harris M. 2006. Polybrominated diphenyl ethers in southern Mississippi catfish. Dioxin 2006, Oslo, Norway, August 2006.

Haws LC, Scott PK, Unice KM, Gough M, Harris MA, Staskal DF, Paustenbach DJ, Pavuk M. Are dioxin body burdens surrogates for other risk factors in associations between dioxin and diabetes? Dioxin 2006, Oslo, Norway, August 2006.

Haws LC, DeVito MJ, Birnbaum LS, Walker NJ, Scott PK, Unice KM, …, Finley BL, Staskal DF. An alternative method for establishing TEFs for dioxin-like compounds: Part 2. Development of an approach to quantitatively weight the underlying potency data. Dioxin 2006, Oslo, Norway, 2006.

Haws L. The use of toxic equivalency factors to assess potential human health risks posed by dioxin-like compounds: Keeping up with the science. Presented at Michigan State University, Toxicology Program Seminar Series, September,, 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walke Nr, Peterson RE. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241; doi: 10.1093/toxsci/kfl055.

Paustenbach DJ, Harris M, Ferriby LL, Williams ES, Haws LC, Unice KM, Scott PK. Development of PCDD/F TEQ serum reference values for the U.S. population for use in evaluating biomonitoring results. Dioxin 2006, Oslo, Norway, August 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, et al. Human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds: The WHO 2005 re-evaluation. Dioxin 2006, Oslo, Norway, August 2006.

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2005, Toronto, Canada, 2005.

Harris M, Finley B. The TCDD TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Society of Toxicology 44th Annual Meeting, New Orleans, LA, 2005.

Harris M, Finley B, Scott P. Development of a relative estimate of potency distribution for 2,3,7,8-TCDF. Dioxin 2005, Toronto, Canada, 2005.

Haws L. Evaluating potential health risks posed by PCDDs, PCDFs, and dioxin-like PCBs: An approach for improving the Toxicity Equivalency Factor (TEF) methodology. 30th Annual Winter Meeting of the Toxicology Forum, Washington, DC, February 2005.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090. PMID: 15659567.

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2004, Berlin, Germany, 2004.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, 2004.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Tissue distribution and elimination of BDE 47 in mice following a single oral dose. Dioxin 2004, Berlin, Germany, September 2004.